Cosmecca Korea
Financials
Valuation Metrics
Cosmecca Korea's Market Cap is ₩9185B. At end of 2025 it was ₩7113B. Ranked #306 of 2,436 in KR market (top 13%), #78 of 1,649 on KOSDAQ (top 5%), #8 of 57 in Household & Personal Products (top 14%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 918.48B KRW | KR#306/2,436 Sec#8/57 |
| Revenue | 707.71B KRW | KR#486/2,436 Sec#7/57 |
| Net Income | 68.24B KRW | KR#295/2,436 Sec#7/57 |
| Total Assets | 677.15B KRW | KR#606/2,436 Sec#9/57 |
| Net Assets | 312.04B KRW | KR#687/2,436 Sec#13/57 |
| Employees | 450 | KR#543/2,436 Sec#11/57 |
| Value | ||
| P/E | 13.46x | KR#910/2,436 Sec#18/57 |
| P/B | 2.94x | KR#2,110/2,436 Sec#49/57 |
| PEG | 0.12x | KR#419/2,436 Sec#12/57 |
| P/S | 1.30x | KR#1,579/2,436 Sec#41/57 |
| EV/EBITDA | 11.18x | KR#672/2,436 Sec#15/57 |
| FCF Yield | -0.69% | KR—/2,436 Sec—/57 |
| Profitability | ||
| ROE | 21.87% | KR#99/2,436 Sec#7/57 |
| ROA | 10.08% | KR#193/2,436 Sec#9/57 |
| Op. Margin | 13.16% | KR#344/2,436 Sec#8/57 |
| Revenue Growth | 56.42% | KR#258/2,436 Sec#4/57 |
| Earnings Growth | 112.79% | KR#388/2,436 Sec#13/57 |
| Financial Health | ||
| Debt Ratio | 117.01% | KR#591/2,436 Sec#19/57 |
| Total Debt | 213.12B KRW | KR#471/2,436 Sec#9/57 |
| FCF | -6.34B KRW | KR#1,569/2,436 Sec#42/57 |
| Cash | 90.68B KRW | KR#494/2,436 Sec#12/57 |
| Current Ratio | 1.28x | KR#1,492/2,436 Sec#35/57 |
| Net Debt/EBITDA | 1.31x | KR#836/2,436 Sec#26/57 |
| Dividend | ||
| Div. Yield | 0.47% | KR#1,298/2,436 Sec#33/57 |
| Div. Growth | 85.00% | KR#154/2,436 Sec#5/57 |
| Performance | ||
| 1Y Return | 34.17% | KR#319/2,436 Sec#5/57 |
| 1M Return | 4.62% | KR#503/2,436 Sec#27/57 |
| From 52W High | -19.17% | KR#176/2,436 Sec#10/57 |
| 1Y MDD | -37.96% | KR#455/2,436 Sec#4/57 |
| Trading | ||
| Volume | 92,892 shares | KR#981/2,436 Sec#21/57 |
| Foreign Own. | 21.47% | KR#200/2,436 Sec#9/57 |
| Per Share | ||
| EPS | 5,159 KRW | KR#169/2,436 Sec#5/57 |
| BPS | 23,795 KRW | KR#445/2,436 Sec#8/57 |
Company Info
Established in 1999 as a cosmetics ODM/OEM company, COSMECCA KOREA secured production bases in Korea, China, and the US through the 2018 acquisition of Englewood Lab in the United States. The company specializes in ODM/OEM manufacturing of basic cosmetics, offering global total service OGM that considers market trends, distribution structures, and regulations. It minimizes defect rates with an automated production system (CPS) and maintains a comprehensive global management system, supported by research personnel and ISO international certifications, while continuously pursuing innovation. COSMECCA KOREA is headquartered in Eumseong-gun, Chungcheongbuk-do.